Axial Spondyloarthritis in the Era of Precision Medicine-Reference-Cited by-同舟云学术

Axial Spondyloarthritis in the Era of Precision Medicine

Published:2020-05 Issue:2 Volume:46 Page:367-378
ISSN:0889-857X
Container-title:Rheumatic Disease Clinics of North America
language:en
Short-container-title:Rheumatic Disease Clinics of North America

Author:

van Bentum Rianne E.,van der Horst-Bruinsma Irene E.

Publisher

Elsevier BV

Subject

Rheumatology

Reference79 articles.

1. The development of Assessment of SpondyloArthritis International Society classification criteria for axial spondyloarthritis (part II): validation and final selection;Rudwaleit;Ann Rheum Dis,2009

2. Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: a meta-analysis;de Winter;Arthritis Res Ther,2016

3. Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis;Stolwijk;Ann Rheum Dis,2015

4. Management and evaluation of extra-articular manifestations in spondyloarthritis;van der Horst-Bruinsma;Ther Adv Musculoskelet Dis,2012

5. Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis);Kroon;Cochrane Database Syst Rev,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pan American League of Associations for Rheumatology recommendations for the management of axial spondyloarthritis;Nature Reviews Rheumatology;2023-10-06

2. The effect of uveitis and undiagnosed spondyloarthritis: a systematic review and meta-analysis;Scientific Reports;2023-09-07

3. Patient-tailored dose reduction of tumor necrosis factor inhibitors in axial spondyloarthritis;International Immunopharmacology;2023-03

4. Ankylosing Spondylitis;Rheumatology for Primary Care Providers;2021-11-09